Core & Main, Inc.
Congress has disclosed 8 buys and 8 sells of CNM (Core & Main, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying CNM and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Michael McCaul | 2025-09-22 | $50.71 | $44.25 | -12.7% | underwater |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Retail & Wholesale. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
16 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| April McClain Delaney | House | SELL ◆ insider divergence · moderate | Child | 2026-08-25 | 7 days | -4.6% | $100K–$250K 0.1% of NW |
65.8 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider divergence · moderate | Child | 2026-06-12 | 19 days | -6.0% | $1K–$15K <0.1% of NW |
17.7 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
1.1 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -0.2% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -0.2% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-09-22 | 13 days | +3.6% | $15K–$50K | 47.5 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-09-11 | 20 days | +6.4% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| April McClain Delaney | House | SELL ◆ insider convergence | Child | 2025-08-04 | 35 days | +4.3% | $15K–$50K <0.1% of NW |
28.7 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | +18.1% | $1K–$15K 0.1% of NW |
27.6 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-11 | 63 days | +14.3% | $1K–$15K 0.1% of NW |
63.6 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence | Child | 2025-04-07 | 24 days | +16.8% | $1K–$15K <0.1% of NW |
25.8 | ↗ filing |
| April McClain Delaney | House | BUY ◆ insider divergence | Child | 2025-02-08 | 21 days | -6.6% | $1K–$15K <0.1% of NW |
62.3 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2024-12-20 | 16 days | +3.1% | $1K–$15K | 15.7 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2024-09-10 | 25 days | +12.9% | $15K–$50K | 56.6 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Child | 2024-09-10 | 25 days | +12.9% | $15K–$50K | 56.6 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2024-08-26 | 10 days | -29.2% | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in CNM — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in CNM, 4 coincided with corporate insiders moving the same way within 60 days, and 9 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-07-06 | Hope James D | Director | BUY | $95K | ↗ EDGAR |
| 2026-04-17 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $86K | ↗ EDGAR |
| 2026-04-17 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $177K | ↗ EDGAR |
| 2026-04-07 | Hope James D | Director | BUY | $100K | ↗ EDGAR |
| 2025-08-18 | Witkowski Mark R | C-suite | SELL 10b5-1 | $6.4M | ↗ EDGAR |
| 2025-07-22 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $323K | ↗ EDGAR |
| 2025-07-18 | Kimbrough Orvin T | Director | SELL 10b5-1 | $1.5M | ↗ EDGAR |
| 2025-07-18 | Castellano James G | Director | SELL 10b5-1 | $2.7M | ↗ EDGAR |
| 2025-07-17 | Witkowski Mark R | C-suite | SELL 10b5-1 | $4.4M | ↗ EDGAR |
| 2025-07-17 | Witkowski Mark R | C-suite | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2025-07-07 | LeClair Stephen O | Director | SELL | $2.8M | ↗ EDGAR |
| 2025-07-03 | LeClair Stephen O | Director | SELL | $5.0M | ↗ EDGAR |
| 2025-07-01 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $801K | ↗ EDGAR |
| 2025-07-01 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $691K | ↗ EDGAR |
| 2025-07-01 | Bradbury Robyn L | C-suite | SELL 10b5-1 | $20K | ↗ EDGAR |
| 2025-06-09 | Whittenburg Mark G | Other | SELL 10b5-1 | $2.9M | ↗ EDGAR |
| 2025-06-06 | Whittenburg Mark G | Other | SELL 10b5-1 | $54K | ↗ EDGAR |
| 2025-06-03 | Schneider Laura K | C-suite | SELL 10b5-1 | $2.6M | ↗ EDGAR |
| 2025-05-28 | Schaller John R | Other | SELL 10b5-1 | $539K | ↗ EDGAR |
| 2025-04-29 | Stephens John Weldon | C-suite | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2025-04-28 | Stephens John Weldon | C-suite | SELL 10b5-1 | $542K | ↗ EDGAR |
| 2025-04-02 | Stephens John Weldon | C-suite | SELL 10b5-1 | $2.1M | ↗ EDGAR |
| 2025-03-11 | Schaller John R | Other | SELL 10b5-1 | $868K | ↗ EDGAR |
| 2025-03-10 | Schaller John R | Other | SELL 10b5-1 | $1.0M | ↗ EDGAR |
| 2025-02-10 | Cowles Bradford A | C-suite | SELL 10b5-1 | $1.4M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-08-25 | April McClain Delaney | SELL | $100K–$250K |
| ◆ insider | 2026-07-06 | Hope James D Director | BUY | $95K |
| Congress | 2026-06-12 | April McClain Delaney | SELL | $1K–$15K |
| ◆ insider | 2026-04-17 | Bradbury Robyn L C-suite 10b5-1 | SELL | $86K |
| ◆ insider | 2026-04-17 | Bradbury Robyn L C-suite 10b5-1 | SELL | $177K |
| ◆ insider | 2026-04-07 | Hope James D Director | BUY | $100K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-09-22 | Michael McCaul | BUY | $15K–$50K |
| Congress | 2025-09-11 | Lisa McClain | BUY | $1K–$15K |
| ◆ insider | 2025-08-18 | Witkowski Mark R C-suite 10b5-1 | SELL | $6.4M |
| Congress | 2025-08-04 | April McClain Delaney | SELL | $15K–$50K |
| ◆ insider | 2025-07-22 | Bradbury Robyn L C-suite 10b5-1 | SELL | $323K |
| ◆ insider | 2025-07-18 | Kimbrough Orvin T Director 10b5-1 | SELL | $1.5M |
| ◆ insider | 2025-07-18 | Castellano James G Director 10b5-1 | SELL | $2.7M |
| ◆ insider | 2025-07-17 | Witkowski Mark R C-suite 10b5-1 | SELL | $4.4M |
| ◆ insider | 2025-07-17 | Witkowski Mark R C-suite 10b5-1 | SELL | $1.7M |
| ◆ insider | 2025-07-07 | LeClair Stephen O Director | SELL | $2.8M |
| ◆ insider | 2025-07-03 | LeClair Stephen O Director | SELL | $5.0M |
| ◆ insider | 2025-07-01 | Bradbury Robyn L C-suite 10b5-1 | SELL | $801K |
| ◆ insider | 2025-07-01 | Bradbury Robyn L C-suite 10b5-1 | SELL | $691K |
| ◆ insider | 2025-07-01 | Bradbury Robyn L C-suite 10b5-1 | SELL | $20K |
| Congress | 2025-06-17 | Lisa McClain | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded CNM?
8 disclosed buys and 8 sells of CNM (Core & Main, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade CNM?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.